Reinforcer Pathology 1B: Decreasing the Temporal Window
| Registry | NCT04128761, acronym RP1B |
|---|---|
| Status | Completed |
| Phase | Not applicable |
| Study type | Interventional; randomized, parallel, masking: single, basic science |
| Enrollment | 124 (Actual) |
| Sponsor | Virginia Polytechnic Institute and State University (Other); collaborators: National Institute on Alcohol Abuse and Alcoholism (NIAAA), McMaster University, Arizona State University, Carilion Clinic, University of Kentucky |
| Conditions | Alcohol Use Disorder |
| Interventions | Scarcity Narrative, Neutral Narrative (Behavioral) |
| Dates | start 2023-09-21, primary completion 2024-05-28, completion 2024-05-28, first posted 2019-10-16, last updated 2025-12-17 |
| Locations | 1 site in United States |
Related Papers Related Patents Related Grants Related Experts
All trials for Alcohol Use Disorder All trials of Scarcity Narrative All trials of Neutral Narrative
In the absence of sufficient monetary resources, individuals must attend to immediate, minimum needs (e.g., food, shelter). This constricts one's temporal window and engenders neglect of the future. In observational studies, scarcity is associated with higher rates of delay discounting. Additionally, socioeconomic status is inversely associated with alcohol use disorder and related problems. Experimentally, scarcity shortens attention, impedes cognitive function, and increases delay discounting in multiple populations. Moreover, scarcity increases demand for fast foods in the obese and increases craving for alcohol in problem drinkers. These data suggest that economic scarcity worsens both components of reinforcer pathology (delay discounting and alcohol overvaluation), thus increasing vulnerability to alcohol use disorder. However, studies investigating the effects of scarcity on alcohol demand discounting rate have been limited. The purpose of Aim 1b is to examine effects of decreasing the temporal window and its concomitant effects on alcohol valuation (demand, and craving) and delay discounting.
Participants will be randomly assigned to experimental or control groups, balanced by discounting rates and sex. We plan to have 112 participants complete the study, based on our power analysis. Participants will complete two online sessions. During the first session, they will complete the baseline assessments. During the second session, they will complete the same assessments after being exposed to the scarcity or control narratives (both in audio format).
The assessment will include delay discounting and demand tasks, and measures of alcohol craving. Participants will also complete assessments of their stress and mood response to the narrative intervention, using the Stress Appraisal Measure (SAM) for two purposes. That is, 1) to monitor participant safety, 2) to measure the mediating ability of affect on changes in the temporal window.
| Arm | Type | Interventions | Description |
|---|---|---|---|
| Scarcity Narrative | Experimental | Behavioral: Scarcity Narrative | Participants assigned to the scarcity group will be asked to listen and consider a hypothetical narrative about a sudden loss of resources. |
| Neutral Narrative | Sham comparator | Behavioral: Neutral Narrative | Participants assigned to the neutral group will be asked to listen and consider a hypothetical narrative about a neutral change in resources. |
Sex: All, ages: 21 Years to any
Inclusion Criteria: * High-risk or harmful drinking (AUDIT>15) * 21 years of age or older * Desire to quit or cut down on their drinking, but do not have proximate plans to enroll in treatment for AUD during the study period Exclusion Criteria: * having a current unmanaged psychotic disorder * reporting current pregnancy or lactation * having dementia
| Milestone | Scarcity Narrative | Neutral Narrative |
|---|---|---|
| Started | 62 | 62 |
| Completed | 57 | 56 |
| Not completed | 5 | 6 |
Time frame: During study participation (approximately 1 week)
| Arm | Deaths | Serious adverse events | Other adverse events |
|---|---|---|---|
| Scarcity Narrative | 0/62 (0.0%) | 0/62 (0.0%) | 0/62 (0.0%) |
| Neutral Narrative | 0/62 (0.0%) | 0/62 (0.0%) | 0/62 (0.0%) |
| Facility | City | Country | Status |
|---|---|---|---|
| Fralin Biomedical Research Institute at VTC | Roanoke, Virginia | United States |
NIH grants: R01AA027381